Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2002

Open Access 01-08-2002 | Research article

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis

Authors: Patrick H Dessein, Anne E Stanwix, Barry I Joffe

Published in: Arthritis Research & Therapy | Issue 5/2002

Login to get access

Abstract

Rheumatoid arthritis (RA) patients experience a markedly increased frequency of cardiovascular disease. We evaluated cardiovascular risk profiles in 79 RA patients and in 39 age-matched and sex-matched osteoarthritis (OA) patients. Laboratory tests comprised ultrasensitive C-reactive protein (CRP) and fasting lipids. Insulin sensitivity (IS) was determined by the Quantitative Insulin Sensitivity Check Index (QUICKI) in all OA patients and in 39 of the RA patients. Ten RA patients were on glucocorticoids. RA patients exercised more frequently than OA patients (χ2 = 3.9, P < 0.05). Nine RA patients and one OA patient had diabetes (χ2 = 4.5, P < 0.05). The median CRP, the mean QUICKI and the mean high-density lipoprotein (HDL) cholesterol were 9 mg/l (range, 0.5–395 mg/l), 0.344 (95% confidence interval [CI], 0.332–0.355) and 1.40 mmol/l (95% CI, 1.30–1.49 mmol/l) in RA patients, respectively, as compared with 2.7 mg/l (range, 0.3–15.9 mg/l), 0.369 (95% CI, 0.356–0.383) and 1.68 mmol/l (95% CI, 1.50–1.85 mmol/l) in OA patients. Each of these differences was significant (P < 0.05). After controlling for the CRP, the QUICKI was similar in RA and OA patients (P = 0.07), while the differences in HDL cholesterol were attenuated but still significant (P = 0.03). The CRP correlated with IS, while IS was associated with high HDL cholesterol and low triglycerides in RA patients and not in OA patients. A high CRP (≥ 8 mg/l) was associated with hypertension (χ2 = 7.4, P < 0.05) in RA patients. RA glucocorticoid and nonglucocorticoid users did not differ in IS and lipids (P > 0.05). Excess cardiovascular risk in RA patients as compared with OA patients includes the presence of decreased IS and HDL cholesterol in RA patients. The latter is only partially attributable to the acute phase response. The CRP, IS, HDL cholesterol, triglycerides and hypertension are inter-related in RA patients, whereas none of these relationships were found in OA patients.
Literature
1.
go back to reference Banks MJ, Flint EJ, Bacon PA, Kitas GD: Prevalence, clinical expression and causes of ischaemic heart disease in rheumatoid arthritis [letter]. Ann Rheum Dis. 2001, 60 (suppl): S47- Banks MJ, Flint EJ, Bacon PA, Kitas GD: Prevalence, clinical expression and causes of ischaemic heart disease in rheumatoid arthritis [letter]. Ann Rheum Dis. 2001, 60 (suppl): S47-
2.
go back to reference del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001, 44: 2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#.PubMedCrossRef del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001, 44: 2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#.PubMedCrossRef
3.
go back to reference Wallberg-Jonsson S, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist K-G, Rantapaa-Dahlqvist S: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol. 2001, 28: 2597-2602. Wallberg-Jonsson S, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist K-G, Rantapaa-Dahlqvist S: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol. 2001, 28: 2597-2602.
4.
go back to reference Wallberg-Jonsson S, Ohman ML, Rantapaa-Dahlqvist S: The epidemiology of vascular disease in rheumatoid arthritis [letter]. Ann Rheum Dis. 2001, 60 (suppl): S8- Wallberg-Jonsson S, Ohman ML, Rantapaa-Dahlqvist S: The epidemiology of vascular disease in rheumatoid arthritis [letter]. Ann Rheum Dis. 2001, 60 (suppl): S8-
5.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
6.
go back to reference Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z: The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol. 2002, 29: 462-466.PubMed Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z: The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol. 2002, 29: 462-466.PubMed
7.
go back to reference Svenson KLG, Pollare T, Lithell H, Hallgren R: Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988, 37: 125-130. 10.1016/S0026-0495(98)90005-1.PubMedCrossRef Svenson KLG, Pollare T, Lithell H, Hallgren R: Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988, 37: 125-130. 10.1016/S0026-0495(98)90005-1.PubMedCrossRef
8.
go back to reference Timar O, Sestier F, Levy E: Metabolic syndrome X: a review. Can J Cardiol. 2000, 16: 779-789.PubMed Timar O, Sestier F, Levy E: Metabolic syndrome X: a review. Can J Cardiol. 2000, 16: 779-789.PubMed
10.
go back to reference Nishimura F, Murayama Y: Periodontal inflammation and insulin resistance – lessons from obesity. J Dent Res. 2001, 80: 1690-1694.PubMedCrossRef Nishimura F, Murayama Y: Periodontal inflammation and insulin resistance – lessons from obesity. J Dent Res. 2001, 80: 1690-1694.PubMedCrossRef
11.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS: The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS: The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.PubMedCrossRef
12.
go back to reference Klippel JH, Weyand CM, Wortmann RL: Criteria for the classification and diagnosis of the rheumatic diseases. In Primer on the Rheumatic Diseases. Edited by: Klippel JH, Weyand CM, Wortmann RL. 1997, Atlanta, Georgia: Arthritis Foundation, 453-464. Klippel JH, Weyand CM, Wortmann RL: Criteria for the classification and diagnosis of the rheumatic diseases. In Primer on the Rheumatic Diseases. Edited by: Klippel JH, Weyand CM, Wortmann RL. 1997, Atlanta, Georgia: Arthritis Foundation, 453-464.
13.
go back to reference Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85: 2402-2410.PubMedCrossRef Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85: 2402-2410.PubMedCrossRef
14.
go back to reference Ridker PM: High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001, 103: 1813-1818.PubMedCrossRef Ridker PM: High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001, 103: 1813-1818.PubMedCrossRef
15.
go back to reference Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999, 26: 2562-2571.PubMed Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999, 26: 2562-2571.PubMed
16.
go back to reference Dessein PH, Stanwix AE: Inflammatory arthritis and cardiovascular disease may share a common predisposition. Rheuma-tology. 2001, 40: 703-704. 10.1093/rheumatology/40.6.703.CrossRef Dessein PH, Stanwix AE: Inflammatory arthritis and cardiovascular disease may share a common predisposition. Rheuma-tology. 2001, 40: 703-704. 10.1093/rheumatology/40.6.703.CrossRef
18.
go back to reference Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med. 2001, 134: 61-71.PubMedCrossRef Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med. 2001, 134: 61-71.PubMedCrossRef
19.
go back to reference Silveri F, Brecciaroli D, Argentati F, Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994, 21: 1899-1902.PubMed Silveri F, Brecciaroli D, Argentati F, Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994, 21: 1899-1902.PubMed
20.
go back to reference Sturmer T, Sun Y, Sauerland S, Zeissig I, Gunther K-P, Puhl W, Brenner H: Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol. 1998, 25: 1827-1832.PubMed Sturmer T, Sun Y, Sauerland S, Zeissig I, Gunther K-P, Puhl W, Brenner H: Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol. 1998, 25: 1827-1832.PubMed
21.
go back to reference Bjorntorp P, Holm G, Rosmond R: Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med. 1999, 16: 373-383. 10.1046/j.1464-5491.1999.00067.x.PubMedCrossRef Bjorntorp P, Holm G, Rosmond R: Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med. 1999, 16: 373-383. 10.1046/j.1464-5491.1999.00067.x.PubMedCrossRef
22.
go back to reference Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, Pedreno J, Vallve JC, Benito P, Wiklund O: Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2761-2767. 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5.PubMedCrossRef Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, Pedreno J, Vallve JC, Benito P, Wiklund O: Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2761-2767. 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5.PubMedCrossRef
23.
go back to reference Wallberg-Jonsson S, Cederfelt M, Rantapaa-Dahlqvist S: Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol. 2000, 27: 71-75.PubMed Wallberg-Jonsson S, Cederfelt M, Rantapaa-Dahlqvist S: Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol. 2000, 27: 71-75.PubMed
24.
go back to reference Svenson KL, Lithell H, Hallgren R, Vessby B: Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. Arch Intern Med. 1987, 147: 1917-1920. 10.1001/archinte.147.11.1917.PubMedCrossRef Svenson KL, Lithell H, Hallgren R, Vessby B: Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. Arch Intern Med. 1987, 147: 1917-1920. 10.1001/archinte.147.11.1917.PubMedCrossRef
Metadata
Title
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis
Authors
Patrick H Dessein
Anne E Stanwix
Barry I Joffe
Publication date
01-08-2002
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2002
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar428

Other articles of this Issue 5/2002

Arthritis Research & Therapy 5/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.